Nilotinib Versus Standard Imatinib (400/600 mg Every Day (QD)) Comparing the Kinetics of Complete Molecular Response for Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) Pts With Evidence of Persistent Leukemia by Real-time Quantitative Polymerase Chain Reaction (RQ-PCR)

Novartis Investigative Site, St Leonards

Novartis Investigative Site, Westmead

Novartis Investigative Site, Parkville

Novartis Investigative Site, Prahran

Novartis Investigative Site, Herston

Novartis Investigative Site, South Brisbane

Novartis Investigative Site, Woolloongabba

Novartis Investigative Site, Adelaide

Novartis Investigative Site, Nedlands

Novartis Investigative Site, Madrid

Novartis Investigative Site, Madrid

Novartis Investigative Site, Málaga

Novartis Investigative Site, Pamplona

Novartis Investigative Site, Bordeaux

Novartis Investigative Site, Vandœuvre-lès-Nancy

Novartis Investigative Site, Lyon

Novartis Investigative Site, Paris

Novartis Investigative Site, Créteil

Novartis Investigative Site, Caba

Novartis Investigative Site, Belo Horizonte

Novartis Investigative Site, Curitiba

Novartis Investigative Site, Rio de Janeiro

Novartis Investigative Site, Campinas

Novartis Investigative Site, São Paulo

Novartis Investigative Site, Vancouver

Novartis Investigative Site, Hamilton

Novartis Investigative Site, Toronto

Novartis Investigative Site, Montreal

Novartis Investigative Site, Québec

Novartis Investigative Site, Barcelona